KLF5 loss sensitizes to ATR inhibition and is synthetic lethal with ARID1A deficiency

ABSTRACT: DRIP-seq experiments conducted in WT U2OS and KLF5 KO U2OS with and without ATR inhibitor treatment

INSTRUMENT(S): Illumina NovaSeq 6000

ORGANISM(S): Homo sapiens

SUBMITTER: Aldo Bader 

PROVIDER: E-MTAB-14062 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress